NHS England |August 2018 |NHS70: spotlight on cancer
More people are surviving cancer than ever before. As we continue to celebrate 70 years of the NHS, we shine the spotlight on some of the key milestones that improved cancer diagnosis, treatment and care over the decades, as well as looking to the future on NHS cancer care.
NHS England will also explore some of the work of the National Cancer Programme, as the NHS implements an ambitious. They have produced a timeline of cancer care improvements in cancer prevention, treatment and care (Source: NHS England).
You can watch the video here:
The NHS has played a major role in advancing cancer treatment and care locally, nationally and globally. In this video, we acknowledge some of the key milestones that marked huge improvements in cancer prevention, treatment and care.
Full details are available from NHS England
University of Edinburgh | June 2018 | Aspirin’s anti-cancer effects revealed
Researchers at the University of Edinburgh have discovered aspirin blocks a key process linked to tumour formation. Although aspirin is recognised for its ability to reduce an individual’s risk of developing colon cancer-if taken regularly- its tumour fighting properties have been little understood. The team looked at the impact of taking aspirin to fight bowel cancer; focusing on a structure found inside cells called the nucleolus. They tested aspirin tumour biopsies removed from patients with colon cancer, and cells grown in the lab. Their research discovered that aspirin blocks TIF-IA a key molecule essential to the functioning of the nucleolus (via University of Edinburgh).
Full press release from University of Edinburgh here
The full article is available to read from Nucleic Acids Research
Chen, J. et al |2018| Identification of a novel TIF-IA–NF-κB nucleolar stress response pathway| Nucleic Acids Research| gky455| https://doi.org/10.1093/nar/gky455
In the media:
BBC News Aspirin ‘helps block tumour formation’
Cancer Research UK
GPs in England, Wales and Northern Ireland are less likely to immediately refer people with possible cancer for tests or to a specialist than those in comparable countries, according to new research published in BMJ Open.
The research shows a link between survival and those countries where GPs were more likely to refer patients immediately and those who did not. The UK based GPs were least likely to refer quickly.
UK cancer survival is lower than each of the other countries examined except for Denmark.
The results from the International Cancer Benchmarking Partnership (ICBP) – a collaboration between six countries from around the world with similar health care systems – reveals striking new evidence for a possible explanation of international survival differences.
via Lower cancer survival in UK linked to delays in referring patients for tests | Cancer Research UK.
Link to research: Rose, P. et al. Explaining variation in cancer survival between eleven jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey. BMJ Open. 2015.
Thousands of children may have been spared serious illness and admission to hospital by the smoking ban in England, research has shown. The law making it illegal to smoke in public indoor places saw 11,000 fewer children being admitted to hospital each year with lung infections, the study found.
Researchers analysed more than 1.6 million hospital admissions of children aged 14 and under across England between 2001 to 2012.
They found that the introduction of the smoking ban in 2007 was followed by an immediate reduction of 13.8 per cent in the number of admissions for lower respiratory tract infections.
Admissions for upper respiratory tract infections also decreased but at a more gradual rate. The sharpest falls were seen in the most deprived children.
Reference: Been, Jasper et al. Smoke-Free Legislation And Childhood Hospitalisations For Respiratory Tract Infections European Respiratory Journal (2015): ERJ-00146-2015. 29 May 2015.
There’s a running joke that if you check your symptoms on the Internet, it will probably diagnose you with cancer.
But there seems to be a growing trend that we are starting to rely more and more on digital technology to help us with our health. For example, WebMD last reported an average of 156 million unique users per month – a 33 per cent increase from the previous year.
Health apps (applications that offer health-related services on your mobile phone or tablet) are flooding the market. And the same goes for wearable technology, or ‘wearables’, like the Fitbit, JawBone and most recently the Apple Watch.
One recent study in JAMA Dermatology, which looked at various skin cancer apps, found that three out of the four apps they examined incorrectly classified at least 30 per cent of melanomasas ‘unconcerning’.
The only one that was accurate wasn’t a diagnostic app at all – it helped people with suspected skin cancer by sending a picture directly to a certified dermatologist.
Another study, this time published in the British Journal of Dermatology, examined 39 skin cancer-focused apps and found that none them had been validated for diagnostic accuracy or usefulness by any established research methods.
View the full story here http://scienceblog.cancerresearchuk.org/2015/04/24/health-apps-a-note-of-caution/
People’s awareness of the idea of ‘overdiagnosis’ in cancer screening is low, and they have varying opinions of how much is acceptable, according to a new study published in The BMJ
Overdiagnosis, or overdetection, of the disease is when cancers are picked up that would never have gone on to cause any harm in a person’s lifetime. Researchers from the University of Oxford’s Nuffield Department of Primary Care Health Sciences carried out a survey of 1,000 people in the UK to examine their views on overdetection. While only one in three (29 per cent) people had heard of overdetection before the study began, results indicated that people were more accepting of it when the potential benefit perceived from screening was higher.
The researchers looked at three hypothetical cancer screening scenarios: breast (for women), prostate (for men) and bowel (for men and women). Online respondents were given the total number of annual cases in the UK and a description of the treatment – including any adverse effects – for each type of cancer. They were also presented with two different screening scenarios: one indicated a 10 per cent reduction in cancer-specific deaths and the second, a 50 per cent reduction. On average, people accepted between 113 to 150 people being overdetected per 1000 people screened. But up to seven per cent of those polled wouldn’t accept any overdetection, while as many as 14 per cent would accept overdetection of the entire screened population.
Link to research: http://www.bmj.com/content/350/bmj.h980
The Department of Health and NHS England have “lost momentum” in improving cancer services in the last two years, MPs have warned. While survival continues to improve, nearly a third of people still die within a year of being diagnosed and around half do not survive for five years. This places the UK in a poor position compared to the rest of Europe, the Commons Public Accounts Committee (PAC) said. Survival and access to treatment are poor for older people in particular, which is especially concerning as three in five cancers are diagnosed in people aged over 65, the report said. It criticised NHS England for not understanding what lies behind the variations and not using the available data to hold poorly performing local areas to account.
View the full report here